REAP Financial Group’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
REAP Financial Group's MDT Position: Q2 2026 in Review
REAP Financial Group reduced its Medtronic (MDT) stake by 14% in Q2 2026, selling an estimated $13.7K and leaving 1,070 shares worth $83.7K. The position accounts for 0.01% of the portfolio, ranked #236.
REAP Financial Group first reported a position in MDT in Q4 2023 and has held it in 11 quarters since. The position peaked at $107K in Q1 2026. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- REAP Financial Group held 1,070 shares of Medtronic worth $83.7K as of Q2 2026.
- REAP Financial Group sold 170 Medtronic shares in Q2 2026, an estimated $13.7K.
- Medtronic made up 0.01% of REAP Financial Group's portfolio in Q2 2026, its #236 holding.
- REAP Financial Group first reported a position in Medtronic in Q4 2023 and has held it in 11 quarters since.
- REAP Financial Group's Medtronic position peaked at $107K in Q1 2026.
- 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on REAP Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.